| PICTET - BIOTECH HI EUR | RVI BIOTECNOLOGÍA | 38,04% | 83,45% | 33,42% | 95,89% |
| JANUS HENDERSON BALANCED A2 USD | MIXTO MODERADO GLOBAL | 8,05% | 34,21% | 33,41% | 124,81% |
| BOUSSARD & GAVAUDAN CONVERTIBLE I USD | RFI EUROPA CONVERTIBLES | 13,80% | 34,76% | 33,40% | · |
| JANUS HENDERSON HF - JAPANESE SMALLER COMPANIES X2 USD | RVI JAPÓN SMALL/MID CAP | 29,14% | 48,69% | 33,39% | 93,20% |
| UBS (LUX) EQUITY FUND - TECH OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | RVI TECNOLOGÍA | 16,78% | 84,16% | 33,39% | 306,02% |
| JPM EMERGING MARKETS OPPORTUNITIES C (DIST) EUR | RVI EMERGENTES CRECIMIENTO | 39,44% | 73,10% | 33,38% | 110,38% |
| CAIXABANK GLOBAL SICAV - CAIXABANK GLOBAL STRATEGY M EUR CAP | MIXTO FLEXIBLE | 13,29% | 41,01% | 33,37% | · |
| AB SICAV I-EUROZONE GROWTH PORTFOLIO S1X USD | RV EURO | 9,60% | 33,87% | 33,36% | 106,42% |
| BGF WORLD HEALTHSCIENCE I2 USD | RVI BIOTECNOLOGÍA | 23,64% | 22,58% | 33,36% | · |
| NEUBERGER BERMAN US EQUITY PREMIUM EUR I ACC (HEDGED) | RENT. ABSOLUTA. | 12,48% | 38,02% | 33,36% | · |
